Subcellular localization of the steroid receptor coactivators (SRCs) and MEF2 in muscle and rhabdomyosarcoma cells

Molecular Endocrinology

Volumn 15, Issue 5, 2001, Pages 783-796

  Shen Liang Chen, ^a   Wang, S C M ^a   Hosking, B ^a   Muscat, G E O ^a  

^a EXELIXIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYADENYLATED RNA; STEROID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; EMBRYO; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SKELETAL MUSCLE;

ACETYLTRANSFERASES; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOPLASM; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONE ACETYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; MADS DOMAIN PROTEINS; MICE; MUSCLE, SKELETAL; MYOGENIC REGULATORY FACTORS; NUCLEAR RECEPTOR COACTIVATOR 2; ONCOGENE PROTEINS; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; SUBCELLULAR FRACTIONS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0035021913     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.15.5.783     Document Type: Article

References (50)

1. Tumors secreting human TNF/cachectin induce cachexia in mice
2. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states
3. The cancer anorexia-cachexia syndrome
4. Childhood cancer
5. Biology and therapy of pediatric rhabdomyosarcoma
6. Rhabdomyosarcoma: Biology and therapy
7. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
8. The intergroup rhabdomyosarcoma study: A preliminary report
9. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins
10. Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis
11. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins
12. Histone acetylation and cancer
13. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation
14. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C
15. The coregulator exchange in transcriptional functions of nuclear receptors
16. HDAC4 deacetylase associates with and represses the MEF2 transcription factor
17. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases
18. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization
19. Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions
20. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
21. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
22. The transcriptional coactivator p/CIP binds CBP and mediates nuclear-receptor function
23. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors
24. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
25. TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1
26. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
27. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2
28. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
29. Nuclear receptor coregulators: Cellular and molecular biology
30. Modifying chromatin and concepts of cancer
31. Consistent fusion of MOZ and TIF2 in AML with inv(8)(p11q13)
32. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2
33. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia
34. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis
35. Reactivation of heritably silenced gene expression in mice
36. To be or not to be active: The stochastic nature of enhancer action
37. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage
38. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors
39. Myocyte enhancer factor (MEF) 2C: A tissue-restricted member of the MEF-2 family of transcription factors
40. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors
41. Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas
42. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity
43. Expression levels of estrogen receptor-α, estrogen receptor-β, coactivators, and corepressors in breast cancer
44. Cofactor competition between the ligandbound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer
45. Relating genotype and phenotype in breast cancer: An analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations
46. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas
47. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers
48. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells
49. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
50. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction